PFAM Search:   
       by Pfam accession/ID, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  

Full view: branches of nodes matching the query are shown completely (Compact view)

(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Clan: Peptidase_AA (368)
(-)
Family: RVP (212)
(-)
Avian myeloblastosis associated virus (MAV) (1)
1MVPB:6-122; B:6-122STRUCTURAL STUDIES OF THE RETROVIRAL PROTEINASE FROM AVIAN MYELOBLASTOSIS ASSOCIATED VIRUS
(-)
Feline immunodeficiency virus (isolate Petaluma) (FIV) (2)
3OGPB:9-115; B:9-115CRYSTAL STRUCTURE OF 6S-98S FIV PROTEASE WITH DARUNAVIR BOUND
3OGQB:9-115; B:9-115CRYSTAL STRUCTURE OF 6S-98S FIV PROTEASE WITH LOPINAVIR BOUND
(-)
Human T-lymphotropic virus 1 (6)
3LINL:6-114; L:6-114; L:6-114; L:6-114; L:6-114; L:6-114; L:6-114; L:6-114; L:6-114; L:6-114; L:6-114; L:6-114CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR, KNI-10562
3LIQB:6-114; B:6-114CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR, KNI-10673
3LITB:6-114; B:6-114THE CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR KNI-10681
3LIVB:6-114; B:6-114CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR KNI-10683
3LIXB:6-114; B:6-114CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR KNI-10729
3LIYF:6-114; F:6-114; F:6-114; F:6-114; F:6-114; F:6-114CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH STATINE-CONTAINING PEPTIDE INHIBITOR
(-)
Human immunodeficiency virus 1 (23)
2RKFB:4-98; B:4-98HIV-1 PR RESISTANT MUTANT + LPV
2PC0A:1004-1098APO WILD-TYPE HIV PROTEASE IN THE OPEN CONFORMATION
2O40A:4-98CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' HIV-1 PROTEASE MOLECULE
2PSUB:4-98; B:4-98CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH CARB-AD37
2PSVB:4-98; B:4-98CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH CARB-KB45
2Q54B:4-98; B:4-98CRYSTAL STRUCTURE OF KB73 BOUND TO HIV-1 PROTEASE
2Q55B:4-98; B:4-98CRYSTAL STRUCTURE OF KK44 BOUND TO HIV-1 PROTEASE
2Q5KB:4-98; B:4-98CRYSTAL STRUCTURE OF LOPINAVIR BOUND TO WILD TYPE HIV-1 PROTEASE
1RQ9B:4-98; B:4-98CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY
1TW7B:4-98; B:4-98WIDE OPEN 1.3A STRUCTURE OF A MULTI-DRUG RESISTANT HIV-1 PROTEASE REPRESENTS A NOVEL DRUG TARGET
3MWSB:104-198; B:104-198CRYSTAL STRUCTURE OF GROUP N HIV-1 PROTEASE
2P3AB:4-98; B:4-98CRYSTAL STRUCTURE OF THE MULTI-DRUG RESISTANT MUTANT SUBTYPE B HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR
2P3CB:4-98; B:4-98CRYSTAL STRUCTURE OF THE SUBTYPE F WILD TYPE HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR
2P3DB:4-98; B:4-98CRYSTAL STRUCTURE OF THE MULTI-DRUG RESISTANT MUTANT SUBTYPE F HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR
3OXCB:104-198; B:104-198WILD TYPE HIV-1 PROTEASE WITH ANTIVIRAL DRUG SAQUINAVIR
1WBKB:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH ASYMMETRIC INHIBITOR, BEA568
1WBMB:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH SYMMETRIC INHIBITOR, BEA450
1MUIB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LOPINAVIR.
1OHRB:4-98; B:4-98VIRACEPT (R) (NELFINAVIR MESYLATE, AG1343): A POTENT ORALLY BIOAVAILABLE INHIBITOR OF HIV-1 PROTEASE
3LZUB:4-98; B:4-98CRYSTAL STRUCTURE OF A NELFINAVIR RESISTANT HIV-1 CRF01_AE PROTEASE VARIANT (N88S) IN COMPLEX WITH THE PROTEASE INHIBITOR DARUNAVIR.
1RPIB:4-98; B:4-98CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY
1RV7B:4-98; B:4-98CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY
3M9FB:4-98; B:4-98HIV PROTEASE COMPLEXED WITH COMPOUND 10B
(-)
Human immunodeficiency virus type 1 group M subtype A (isolate U455) (HIV-1) (1)
3LZSB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 CRF01_AE PROTEASE IN COMPLEX WITH DARUNAVIR
(-)
Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2) (HIV-1) (34)
1KJ4D:4-98; D:4-98; D:4-98; D:4-98SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES
1KJ7B:4-98; B:4-98SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES
1KJFB:4-98; B:4-98SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES
1KJGB:4-98; B:4-98SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES
1KJHB:4-98; B:4-98SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES
1KZKB:4-98; B:4-98JE-2147-HIV PROTEASE COMPLEX
1MT7B:4-98; B:4-98VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY
1MTBB:4-98; B:4-98VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY
1MTRB:4-98; B:4-98HIV-1 PROTEASE COMPLEXED WITH A CYCLIC PHE-ILE-VAL PEPTIDOMIMETIC INHIBITOR
1N49D:4-98; D:4-98; D:4-98; D:4-98VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE VARIANT: STRUCTURAL INSIGHTS FOR BETTER ANTI-VIRAL THERAPY
1T3RB:4-98; B:4-98HIV PROTEASE WILD-TYPE IN COMPLEX WITH TMC114 INHIBITOR
1TSQB:4-98; B:4-98CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT
1TSUB:4-98; B:4-98CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT
1YTGB:4-98; B:4-98SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT
1YTHB:4-98; B:4-98SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT
1Z1HB:104-198; B:104-198HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 3
1Z1RB:104-198; B:104-198HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 2
2JE4B:4-98; B:4-98ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE IN COMPLEX WITH JG-365
2NXDB:4-98; B:4-98STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH RT-RH ANALOGUE PEPTIDE GLY-ALA-ASP-ILE-PHE*TYR-LEU-ASP-GLY-ALA
2NXLB:4-98; B:4-98STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH THE RT-RH ANALOGUE PEPTIDE GLY-ALA-GLU-VAL-PHE*TYR-VAL-ASP-GLY-ALA
2NXMB:4-98; B:4-98STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH THE RT-RH ANALOGUE PEPTIDE GLY-ALA-GLN-THR-PHE*TYR-VAL-ASP-GLY-ALA
2Q3KB:4-98; B:4-98CRYSTAL STRUCTURE OF LYSINE SULFONAMIDE INHIBITOR REVEALS THE DISPLACEMENT OF THE CONSERVED FLAP WATER MOLECULE IN HIV-1 PROTEASE
2QHYB:4-98; B:4-98CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-AC86 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QHZB:4-98; B:4-98CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-AC87 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI0B:4-98; B:4-98CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-KK80 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI1B:4-98; B:4-98CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-KK81 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI4B:4-98; B:4-98CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-AD93 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI5B:4-98; B:4-98CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-KC08 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI6B:4-98; B:4-98CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-KB98 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI7B:4-98; B:4-98CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-AD86 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
3LZVB:4-98; B:4-98STRUCTURE OF NELFINAVIR-RESISTANT HIV-1 PROTEASE (D30N/N88D) IN COMPLEX WITH DARUNAVIR.
3MXDB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE INHIBITOR KC53 IN COMPLEX WITH WILD-TYPE PROTEASE
3MXEB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE INHIBITOR, KC32 COMPLEXED WITH WILD-TYPE PROTEASE
3OY4B:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 L76V PROTEASE IN COMPLEX WITH THE PROTEASE INHIBITOR DARUNAVIR.
(-)
Human immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1) (27)
1MERB:4-98; B:4-98HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450
1METB:4-98; B:4-98HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323
1MEUB:4-98; B:4-98HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323
1NPAB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE-HUP
1NPVB:204-298; B:204-298CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LDC271
1NPWB:204-298; B:204-298CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH LGZ479
1SBGB:4-98; B:4-98AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLACEMENT. CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSIS
1T7KB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH ARYLSULFONAMIDE AZACYCLIC UREA
1W5VB:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
1W5WB:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
1W5XB:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
1W5YB:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
1YT9B:4-98; B:4-98HIV PROTEASE WITH OXIMINOARYLSULFONAMIDE BOUND
1ZP8A:4-98HIV PROTEASE WITH INHIBITOR AB-2
1ZPAA:4-98HIV PROTEASE WITH SCRIPPS AB-3 INHIBITOR
1ZSRB:104-198; B:104-198CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE (BRU ISOLATE) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[S-CH(OH) CH2NH]-PHE-GLU-PHE-NH2
2UXZB:104-198; B:104-198TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC
2UY0B:104-198; B:104-198TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC
3NU3B:104-198; B:104-198WILD TYPE HIV-1 PROTEASE WITH ANTIVIRAL DRUG AMPRENAVIR
3NU4B:104-198; B:104-198CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT V32I WITH ANTIVIRAL DRUG AMPRENAVIR
3NU5B:104-198; B:104-198CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT I50V WITH ANTIVIRAL DRUG AMPRENAVIR
3NU6B:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT I54M WITH ANTIVIRAL DRUG AMPRENAVIR
3NU9B:104-198; B:104-198CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT I84V WITH ANTIVIRAL DRUG AMPRENAVIR
3NUJB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT I54V WITH ANTIVIRAL DRUG AMPRENAVIR
3NUOB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT L90M WITH ANTIVIRAL DRUG AMPRENAVIR
3OK9B:104-198; B:104-198CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE WITH NEW OXATRICYCLIC DESIGNED INHIBITOR GRL-0519A
3TLHA:4-98STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN EFFICIENT INHIBITOR OF FIV PR
(-)
Human immunodeficiency virus type 1 group M subtype B (isolate BH5) (HIV-1) (13)
1K1TB:104-198; B:104-198COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE
1K1UB:104-198; B:104-198COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE
1K2BB:4-98; B:4-98COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE
1K2CB:4-98; B:4-98COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE
1ODXB:4-98; B:4-98HIV-1 PROTEINASE MUTANT A71T, V82A
1Q9PA:4-94SOLUTION STRUCTURE OF THE MATURE HIV-1 PROTEASE MONOMER
1TCXB:4-98; B:4-98HIV TRIPLE MUTANT PROTEASE COMPLEXED WITH INHIBITOR SB203386
2NMYB:104-198; B:104-198CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A INHIBITOR SAQUINAVIR
2NMZB:104-198; B:104-198CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A INHIBITOR SAQUINAVIR
2NNKB:104-198; B:104-198CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A INHIBITOR SAQUINAVIR
2NNPB:104-198; B:104-198CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A INHIBITOR SAQUINAVIR
2R38B:4-98; B:4-98I84V HIV-1 PROTEASE MUTANT IN COMPLEX WITH A CARBAMOYL DECORATED PYRROLIDINE-BASED INHIBITOR
2R3TB:4-98; B:4-98I50V HIV-1 PROTEASE MUTANT IN COMPLEX WITH A CARBAMOYL DECORATED PYRROLIDINE-BASED INHIBITOR
(-)
Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) (HIV-1) (55)
1LZQB:104-198; B:104-198CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH AN ETHYLENAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[CH2CH2NH]-PHE-GLU-PHE-NH2
1M0BB:104-198; B:104-198HIV-1 PROTEASE IN COMPLEX WITH AN ETHYLENEAMINE INHIBITOR
1MRWB:4-98; B:4-98STRUCTURE OF HIV PROTEASE (MUTANT Q7K L33I L63I) COMPLEXED WITH KNI-577
1MSMB:4-98; B:4-98THE HIV PROTEASE (MUTANT Q7K L33I L63I) COMPLEXED WITH KNI-764 (AN INHIBITOR)
1MSNB:4-98; B:4-98THE HIV PROTEASE (MUTANT Q7K L33I L63I V82F I84V) COMPLEXED WITH KNI-764 (AN INHIBITOR)
1NH0B:4-98; B:4-981.03 A STRUCTURE OF HIV-1 PROTEASE: INHIBITOR BINDING INSIDE AND OUTSIDE THE ACTIVE SITE
1RL8B:4-98; B:4-98CRYSTAL STRUCTURE OF THE COMPLEX OF RESISTANT STRAIN OF HIV-1 PROTEASE(V82A MUTANT) WITH RITONAVIR
1SDTB:104-198; B:104-198CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE.
1SDUB:104-198; B:104-198CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE.
1SDVB:104-198; B:104-198CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE.
1SGUB:4-98; B:4-98COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE
1SH9B:4-98; B:4-98COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE
1SP5B:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH A PRODUCT OF AUTOPROTEOLYSIS
1U8GB:4-98; B:4-98CRYSTAL STRUCTURE OF A HIV-1 PROTEASE IN COMPLEX WITH PEPTIDOMIMETIC INHIBITOR KI2-PHE-GLU-GLU-NH2
1UPJA:4-98HIV-1 PROTEASE COMPLEX WITH U095438 [3-[1-(4-BROMOPHENYL) ISOBUTYL]-4-HYDROXYCOUMARIN
1XL2B:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH PYRROLIDINMETHANAMINE
1XL5B:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH AMIDHYROXYSULFONE
1Z8CB:104-198; B:104-198CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (L63P, A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2
1ZBGB:104-198; B:104-198CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2
1ZJ7A:4-98CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[S-CH(OH)CH2NH]-PHE-GLU-PHE-NH2
1ZLFB:104-198; B:104-198CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR
1ZPKB:104-198; B:104-198CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2
1ZTZB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV PROTEASE- METALLACARBORANE COMPLEX
2O4LB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, I50V) IN COMPLEX WITH TIPRANAVIR
2O4NB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE (TRM MUTANT) IN COMPLEX WITH TIPRANAVIR
2O4PB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K) IN COMPLEX WITH TIPRANAVIR
2O4SB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K) IN COMPLEX WITH LOPINAVIR
2P3BB:4-98; B:4-98CRYSTAL STRUCTURE OF THE SUBTYPE B WILD TYPE HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR
2PK5B:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I ) IN COMPLEX WITH KNI-10075
2PK6B:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10033
2PQZB:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH A PYRROLIDINE-BASED INHIBITOR
2PWCB:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH A AMINO DECORATED PYRROLIDINE-BASED INHIBITOR
2PWRB:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH A CARBAMOYL DECORATED PYRROLIDINE-BASED INHIBITOR
2PYMB:4-98; B:4-98HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR
2PYNB:4-98; B:4-98HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR
2Q63B:4-98; B:4-98HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR
2Q64B:4-98; B:4-98HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR
2QAKB:4-98; B:4-98HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR
2QCIB:104-198; B:104-198HIV-1 PROTEASE MUTANT D30N WITH POTENT ANTIVIRAL INHIBITOR GRL-98065
2QD7B:104-198; B:104-198HIV-1 PROTEASE MUTANT V82A WITH POTENT ANTIVIRAL INHIBITOR GRL-98065
2QHCB:4-98; B:4-98THE INFLUENCE OF I47A MUTATION ON REDUCED SUSCEPTIBILITY TO THE PROTEASE INHIBITOR LOPINAVIR
2QNNB:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH A MULTIPLE DECORATED PYRROLIDINE-BASED INHIBITOR
2QNQB:4-98; B:4-98HIV-1 PROTEASE IN COMPLEX WITH A CHLORO DECORATED PYRROLIDINE-BASED INHIBITOR
2R43B:4-98; B:4-98I50V HIV-1 PROTEASE IN COMPLEX WITH AN AMINO DECORATED PYRROLIDINE-BASED INHIBITOR
2UPJB:4-98; B:4-98HIV-1 PROTEASE COMPLEX WITH U100313 ([3-[[3-[CYCLOPROPYL [4-HYDROXY-2OXO-6-[1-(PHENYLMETHYL)PROPYL]-2H-PYRAN-3-YL] METHYL]PHENYL]AMINO]-3-OXO-PROPYL]CARBAMIC ACID TERT-BUTYL ESTER)
2Z4OB:104-198; B:104-198WILD TYPE HIV-1 PROTEASE WITH POTENT ANTIVIRAL INHIBITOR GRL-98065
2ZGAA:4-98HIV-1 PROTEASE IN COMPLEX WITH A DIMETHYLALLYL DECORATED PYRROLIDINE BASED INHIBITOR (HEXAGONAL SPACE GROUP)
2ZYEB:104-198; B:104-198STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH POTENT INHIBITOR KNI-272 DETERMINED BY NEUTRON CRYSTALLOGRAPHY
3JVWB:104-198; B:104-198HIV-1 PROTEASE MUTANT G86A WITH SYMMETRIC INHIBITOR DMP323
3JW2B:104-198; B:104-198HIV-1 PROTEASE MUTANT G86S WITH DARUNAVIR
3KDBB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10006
3KDCB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10074
3KDDB:4-98; B:4-98CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10265
3PWMB:104-198; B:104-198HIV-1 PROTEASE MUTANT L76V WITH DARUNAVIR
3PWRB:104-198; B:104-198HIV-1 PROTEASE MUTANT L76V COMPLEXED WITH SAQUINAVIR
(-)
Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) (HIV-1) (12)
1LV1A:1004-1098CRYSTAL STRUCTURE ANALYSIS OF THE NON-ACTIVE SITE MUTANT OF TETHERED HIV-1 PROTEASE TO 2.1A RESOLUTION
1ODWB:4-98; B:4-98NATIVE HIV-1 PROTEINASE
1ODYB:4-98; B:4-98HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130
1QBRB:4-98; B:4-98HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY
1QBSB:4-98; B:4-98HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY
1QBUB:4-98; B:4-98HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY
2NPHB:1004-1098; B:1004-1098CRYSTAL STRUCTURE OF HIV1 PROTEASE IN SITU PRODUCT COMPLEX
2WHHA:4-98HIV-1 PROTEASE TETHERED DIMER Q-PRODUCT COMPLEX ALONG WITH NUCLEOPHILIC WATER MOLECULE
3KT2A:4-98CRYSTAL STRUCTURE OF N88D MUTANT HIV-1 PROTEASE
3KT5A:1004-1098CRYSTAL STRUCTURE OF N88S MUTANT HIV-1 PROTEASE
3MIMB:1004-1098; B:1004-1098X-RAY SNAPSHOT OF HIV-1 PROTEASE IN ACTION: OBSERVATION OF TETRAHEDRAL INTERMEDIATE AND ITS SIHB WITH CATALYTIC ASPARTATE
3N3IA:4-98CRYSTAL STRUCTURE OF G48V/C95F TETHERED HIV-1 PROTEASE/SAQUINAVIR COMPLEX
(-)
Human immunodeficiency virus type 1 group M subtype B (isolate YU-2) (HIV-1) (18)
1K6CB:4-98; B:4-98LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE
1K6PB:4-98; B:4-98LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE
1K6TB:4-98; B:4-98LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE
1K6VB:4-98; B:4-98LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE
1T7JB:4-98; B:4-98CRYSTAL STRUCTURE OF INHIBITOR AMPRENAVIR IN COMPLEX WITH A MULTI-DRUG RESISTANT VARIANT OF HIV-1 PROTEASE (L63P/V82T/I84V)
3OQ7A:4-98CRYSTAL STRUCTURES OF MULTIDRUG-RESISTANT CLINICAL ISOLATE 769 HIV-1 PROTEASE VARIANTS
3OQAA:4-98CRYSTAL STRUCTURES OF MULTIDRUG-RESISTANT CLINICAL ISOLATE 769 HIV-1 PROTEASE VARIANTS
3OQDA:4-98CRYSTAL STRUCTURES OF MULTIDRUG-RESISTANT CLINICAL ISOLATE 769 HIV-1 PROTEASE VARIANTS
3OTSB:4-98; B:4-98MDR769 HIV-1 PROTEASE COMPLEXED WITH MA/CA HEPTA-PEPTIDE
3OTYB:4-98; B:4-98MDR769 HIV-1 PROTEASE COMPLEXED WITH RT/RH HEPTA-PEPTIDE
3OU1B:4-98; B:4-98MDR769 HIV-1 PROTEASE COMPLEXED WITH RH/IN HEPTA-PEPTIDE
3OU3B:4-98; B:4-98MDR769 HIV-1 PROTEASE COMPLEXED WITH PR/RT HEPTA-PEPTIDE
3OU4B:4-98; B:4-98MDR769 HIV-1 PROTEASE COMPLEXED WITH TF/PR HEPTA-PEPTIDE
3OUAB:4-98; B:4-98MDR769 HIV-1 PROTEASE COMPLEXED WITH P1/P6 HEPTA-PEPTIDE
3OUBB:4-98; B:4-98MDR769 HIV-1 PROTEASE COMPLEXED WITH NC/P1 HEPTA-PEPTIDE
3OUCB:4-98; B:4-98MDR769 HIV-1 PROTEASE COMPLEXED WITH P2/NC HEPTA-PEPTIDE
3OUDB:4-98; B:4-98MDR769 HIV-1 PROTEASE COMPLEXED WITH CA/P2 HEPTA-PEPTIDE
3PJ6A:4-98CRYSTAL STRUCTURES OF MULTIDRUG-RESISTANT CLINICAL ISOLATE 769 HIV-1 PROTEASE VARIANTS
(-)
Human immunodeficiency virus type 1 group M subtype C (isolate 92BR025) (HIV-1) (2)
2R5QD:4-98; D:4-98; D:4-98; D:4-98CRYSTAL STRUCTURE ANALYSIS OF HIV-1 SUBTYPE C PROTEASE COMPLEXED WITH NELFINAVIR
2R8NA:4-98STRUCTURAL ANALYSIS OF THE UNBOUND FORM OF HIV-1 SUBTYPE C PROTEASE
(-)
Human immunodeficiency virus type 1 group M subtype D (isolate Z2/CDC-Z34) (HIV-1) (10)
1PROB:4-98; B:4-98HIV-1 PROTEASE DIMER COMPLEXED WITH A-98881
1VIJB:4-98; B:4-98HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR HOE/BAY 793 HEXAGONAL FORM
1VIKB:4-98; B:4-98HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR HOE/BAY 793 ORTHORHOMBIC FORM
2WKZB:104-198; B:104-198HIV-1 PROTEASE INHIBITORS CONTAINING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMIC WITH IMPROVED CELL-BASED ANTIVIRAL ACTIVITY
2WL0B:104-198; B:104-198HIV-1 PROTEASE INHIBITORS CONTAINING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMIC WITH IMPROVED CELL-BASED ANTIVIRAL ACTIVITY
3KF0B:4-98; B:4-98HIV PROTEASE WITH FRAGMENT 4D9 BOUND
3KFNB:4-98; B:4-98HIV PROTEASE (PR) WITH INHIBITOR TL-3 AND FRAGMENT HIT 4D9 BY SOAKING
3KFPA:4-98HIV PROTEASE (PR) WITH INHIBITOR TL-3 BOUND, AND DMSOS IN EXO SITE
3KFRB:4-98; B:4-98HIV PROTEASE (PR) DIMER WITH INHIBITOR TL-3 BOUND AND FRAGMENT 1F1 IN THE OUTSIDE/TOP OF FLAP
3KFSB:4-98; B:4-98HIV PROTEASE (PR) DIMER WITH INHIBITOR TL-3 BOUND AND FRAGMENT 2F4 IN THE OUTSIDE/TOP OF FLAP
(-)
Human immunodeficiency virus type 2 subtype A (isolate ROD) (HIV-2) (2)
1JLDB:4-98; B:4-98POTENT HIV PROTEASE INHIBITORS CONTAINING A NOVEL (HYDROXYETHYL)AMIDE ISOSTERE
2MIPD:4-98; D:4-98; D:4-98; D:4-98CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES
(-)
Rous sarcoma virus (strain Prague C) (RSV-PrC) (1)
2RSPB:6-122; B:6-122STRUCTURE OF THE ASPARTIC PROTEASE FROM ROUS SARCOMA RETROVIRUS REFINED AT 2 ANGSTROMS RESOLUTION
(-)
Simian immunodeficiency virus (isolate Mm142-83) (SIV-mac) (Simian immunodeficiency virus rhesus mon (4)
1SIVB:4-98; B:4-98THREE-DIMENSIONAL STRUCTURE OF A SIV PROTEASE(SLASH)INHIBITOR COMPLEX. IMPLICATIONS FOR THE DESIGN OF HIV-1 AND HIV-2 PROTEASE INHIBITORS
1TCWB:4-98; B:4-98SIV PROTEASE COMPLEXED WITH INHIBITOR SB203386
1YTIA:4-98SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT
1YTJA:4-98SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT
(-)
Xenotropic MuLV-related virus (isolate VP62) (XMRV) (1)
3NR6B:12-106; B:12-106CRYSTAL STRUCTURE OF XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS (XMRV) PROTEASE